Dudediligence.

Alnylam Pharmaceuticals, Inc

ALNYNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$24.5M

12 notices · 61,099 sh

Oct 2025 to Oct 2026

Reported ·

$43.6M

278 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

136 of 278 reported sales carry the 10b5-1 box. Together they are 0.09% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-02: SUPRAN BRYAN, Form 1442026-06-01: PYOTT DAVID E I, Form 1442026-04-06: McLaughlin Melissa, Form 1442026-03-05: Fitzgerald Kevin Joseph, Form 1442026-03-05: Garg Pushkal, Form 1442026-03-03: Fitzgerald Kevin Joseph, Form 1442026-03-03: Garg Pushkal, Form 1442026-02-27: Garg Pushkal, Form 1442026-02-17: Fitzgerald Kevin Joseph, Form 1442026-01-13: Fitzgerald Kevin Joseph, Form 1442025-11-17: Fitzgerald Kevin Joseph, Form 1442025-11-12: Greenstreet Yvonne, Form 1442025-11-12: Greenstreet Yvonne, sold2025-11-17: Fitzgerald Kevin Joseph, sold2026-01-12: Fitzgerald Kevin Joseph, sold2026-01-12: Tanguler Tolga, sold2026-01-12: Poulton Jeffrey V., sold2026-01-12: Greenstreet Yvonne, sold2026-01-12: Garg Pushkal, sold2026-02-13: Poulton Jeffrey V., sold2026-02-13: Fitzgerald Kevin Joseph, sold2026-02-13: Tanguler Tolga, sold2026-02-13: Greenstreet Yvonne, sold2026-02-13: Garg Pushkal, sold2026-02-27: Garg Pushkal, sold2026-03-02: Greenstreet Yvonne, sold2026-03-02: Tanguler Tolga, sold2026-03-02: Fitzgerald Kevin Joseph, sold2026-03-02: Garg Pushkal, sold2026-03-02: Poulton Jeffrey V., sold2026-03-04: Fitzgerald Kevin Joseph, sold2026-03-04: Tanguler Tolga, sold2026-03-04: Poulton Jeffrey V., sold2026-03-04: Greenstreet Yvonne, sold2026-03-04: Garg Pushkal, sold2026-04-02: McLaughlin Melissa, sold2026-06-01: PYOTT DAVID E I, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-02SUPRAN BRYAN, EVP, CLO and Secretary$398,862
1,758 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-01PYOTT DAVID E I, Director$1,147,123
3,830 shplan 2025-11-12144 ↗
Form 4, 2026-06-03: sold 3,830 at $299.18 Form 4 ↗
2026-04-06McLaughlin Melissa, Chief Human Resources Officer$731,749
2,286 shplan 2025-12-16Form 4s on file end Jun 23144 ↗
2026-03-05Fitzgerald Kevin Joseph, CSO & EVP, Head of Research$212,988
658 shplan 2025-08-14no Form 4 on file144 ↗
2026-03-05Garg Pushkal, EVP Chief R&D$778,151
2,404 shplan 2025-11-20no Form 4 on file144 ↗
2026-03-03Fitzgerald Kevin Joseph, CSO & EVP, Head of Research$530,903
1,652 shplan 2025-08-14144 ↗
Form 4, 2026-03-06: sold 1,291 at $323.54 Form 4 ↗
2026-03-03Garg Pushkal, EVP Chief R&D$570,432
1,775 shplan 2025-11-20144 ↗
Form 4, 2026-03-06: sold 4,713 at $323.53 Form 4 ↗
2026-02-27Garg Pushkal, EVP Chief R&D$1,533,107
4,627 shplan 2024-11-20144 ↗
Form 4, 2026-03-02: sold 4,627 at $331.34 Form 4 ↗
2026-02-17Fitzgerald Kevin Joseph, CSO & EVP, Head of Research$677,532
2,041 shplan 2025-08-14144 ↗
Form 4, 2026-03-04: sold 3,250 at $323.62 Form 4 ↗
2026-01-13Fitzgerald Kevin Joseph, CSO & EVP, Head of Research$845,239
2,290 shplan 2025-08-14144 ↗
Form 4, 2026-02-17: sold 4,000 at $321.24 Form 4 ↗
2025-11-17Fitzgerald Kevin Joseph, CSO & EVP, Head of Research$5,445,472
12,128 shplan 2025-08-14144 ↗
Form 4, 2025-11-19: sold 12,128 at $452.18 Form 4 ↗
2025-11-12Greenstreet Yvonne, Chief Executive Officer$11.6M
25,650 shplan 2024-08-13144 ↗
Form 4, 2025-11-14: sold 25,650 at $452.75 Form 4 ↗